Podcasts about Pharma

Angel Studios https://Angel.com/HermanJoin the Angel Guild today and know you are not just watching, you're helping make bold, faith driven stories like Disciples in the Moonlight possible. That's Angel.com/HermanRenue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comRegister now for the free Review/Preview Webinar November 20th 3:30pm Pacific, schedule your free Know Your Risk Portfolio Review, and subscribe to Zach's Daily Market Recap at (SLOW) Know Your Risk Podcast dot com. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/toddThe new GOLDEN AGE is here!  Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.The ultimate unholy union is government and healthcare. President Trump has put out some words on government and healthcare, and President Trump, is a good friend of big Pharma.Episode Links:Democrat Senator Peter Welch on Obamacare: "We did fail to bring down the cost of healthcare."American doctor goes over how Barack Obama destroyed American HealthcareObamacare is only 7% of Americans. Literally almost 100% of Americans need relief from their health care policy premiums, not just 7%. We need to have free market solutions that bring down the cost of health care for every American, not just the 7%.The Danish Cow Crisis: Bill Gates, “Bovaer,” and the War on Nature. In Denmark, farmers are raising alarms after a new climate-driven feed additive called Bovaer became mandatory on October 1, 2025.Virtually everything that Obama promised about Obamacare was a lie. Now the country is stuck dealing with the ramifications. Instead of taking responsibility, Democrats have shut down the government and are demanding that Republicans fix what they broke.

Canadian journalist Nora Loreto reads the latest headlines for Wednesday, November 12, 2025.TRNN has partnered with Loreto to syndicate and share her daily news digest with our audience. Tune in every morning to the TRNN podcast feed to hear the latest important news stories from Canada and worldwide.Find more headlines from Nora at Sandy & Nora Talk Politics podcast feed.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-news-podcast--2952221/support.Help us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Follow us on:Bluesky: @therealnews.comFacebook: The Real News NetworkTwitter: @TheRealNewsYouTube: @therealnewsInstagram: @therealnewsnetworkBecome a member and join the Supporters Club for The Real News Podcast today!

Pharma juggernauts Pfizer and Novo Nordisk are struggling in the obesity drug race.The two companies are searching for their next moneymaker, and that search recently spun out into a ferocious, multibillion-dollar battle for control of biotech start-up Metsera. The FT's US deals and activism correspondent Oliver Barnes walks through the tussle that's involved lawsuits, public barbs and political drama. Clips from CNBC, Pfizer, Yahoo Finance- - - - - - - - - - - - - - - - - - - - - - - - - - For further reading and listening:Weight-loss wars: $10bn hostile battle pits Pfizer against Novo NordiskPfizer shows hardball mettle needed to win in 2025 M&AThere is only one winner in the Pfizer Novo Nordisk showdownOzempic's unconventional origins- - - - - - - - - - - - - - - - - - - - - - - - - - Attend the FT Global Banking Summit, 2-4 December in London: Enter SAVE20 for a 20% discount, register here.- - - - - - - - - - - - - - - - - - - - - - - - - - Follow Oliver Barnes on X (@mroliverbarnes), or on Bluesky (@mroliverbarnes.bsky.social) Michela Tindera is on X (@mtindera07) and Bluesky (@mtindera.ft.com), or follow her on LinkedIn for updates about the show and more. Hosted on Acast. See acast.com/privacy for more information.

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über Robotikfantasie bei Xpeng, die Weihnachtsüberraschung von FedEx und den Shutdown-Schub für Pharma. Außerdem geht es um Merck, Johnson&Johnson, Amgen, CoreWeave, Nvidia, Softbank, Micron, Oracle, Palantir, Merck KGaA, Siemens Healthineers, UPS, Bayer, Amazon, Alphabet, Microsoft, iShares Core MSCI World ETF (WKN: A0RPWH), Amundi MSCI All Country World ETF (WKN: LYX00C), Vanguard S&P 500 ETF (WKN: A1JX53), iShares Nasdaq 100 ETF (WKN: A0YEDL), Amundi Core Stoxx Europe 600 ETF (WKN: LYX0Q0), Xtrackers MSCI Japan ETF (WKN: DBX1MJ), iShares MSCI China ETF (WKN: A2PGQN), Xtrackers Artificial Intelligence & Big Data ETF (WKN: A2N6LC), Alphabet, Apple, Nvidia und Palantir, Euwax Gold II (WKN: EWG2LD), Xetra Gold (WKN: A0S9GB), Global X Infrastructure ETF (WKN: A40E7B), Vanguard FTSE All World (WKN: A2PKXG), SPDR MSCI All Country World ETF (WKN: A1JJTC), Xtrackers MSCI Emerging Markets ETF (WKN: A12GVR), Vanguard FTSE Emerging Markets ETF (WKN: A2PLTC), iShares EUR High Yield Corporate Bond (WKN: A2DUCZ) und PIMCO Euro Short-Term High Yield Corporate Bond (WKN: A2DLP1). Unter diesem Link könnt ihr euch kostenlos für die Masterclass anmelden: https://form.jotform.com/Product_Unit/masterclass-boersenweisheiten. Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

In search of the next miracle “cure,” Big Pharma has become very proficient at developing highly effective and obscenely profitable drugs aimed at treating rare diseases (think $750,000 per year) at the expense of ignoring newer, safer and effective treatments geared to a wider audience.Alex Martinez, CEO and cofounder of Intrinsic Medicine, shares his amazing journey from being a healthcare attorney who witnessed the good, bad and mostly ugly in Big Pharma to revolutionizing how we care for the human microbiome this week on Spirit Gym. Learn more about Alex's Intrinsic Medicine company at his website. Find him on social media via LinkedIn.Show Notes8:47 “The mission was attractive to me.”12:27 Alex got the education he needed while ground-truthing at the same time.20:50 Why is Big Pharma's disproportionate focus on drugs that treat rare diseases?30:16 Evolutionary biology.39:07 Alex is a very intelligent vegetable.44:42 Human milk oligosaccharides (HMOs) formulated with information molecules.51:53 The fecal transplant isn't new science.1:06:46 Freediving helped Alex look inward toward the microbiome.1:13:26 “What's inside of us is all around us.”1:25:05 The HMOs in breast milk serve as training mechanisms in a baby's gut.1:36:05 Is it possible that HMOs could work one day like fecal transplants?1:44:47 Where do these HMOs originate?1:50:33 Formulating infant formulas that aren't inflammatory should be the norm but aren't.2:07:29 Creating an ethical regenerative business by integrating humanity into it.2:12:49 Humans are so good at finding comfort in dis-ease.2:25:34 Where probiotics went wrong.Resources BifidobacteriumFructooligosaccharides (FOS)Paul's Living 4D conversation with Dr. Nathan RileyThe Abdominal and Pelvic Brain by Byron RobinsonFind more resources for this episode on our website.Music Credit: Meet Your Heroes (444Hz), Composed, mixed, mastered and produced by Michael RB Schwartz of Brave Bear MusicThanks to our awesome sponsors:PaleovalleyBIOptimizers US and BIOptimizers UK PAUL15Organifi CHEK20Wild PasturesKorrect SPIRITGYMPique LifeCHEK Institute We may earn commissions from qualifying purchases using affiliate links.

EPISODE DESCRIPTION:Libby Amber Shayo didn't just survive the pandemic—she branded it. Armed with a bun, a New York accent, and enough generational trauma to sell out a two-drink-minimum crowd, she turned her Jewish mom impressions into the viral sensation known as Sheryl Cohen. What started as one-off TikToks became a career in full technicolor: stand-up, sketch, podcasting, and Jewish community building.We covered everything. Jew camp lore. COVID courtship. Hannah Montana. Holocaust comedy. Dating app postmortems. And the raw, relentless grief that comes with being Jewish online in 2025. Libby's alter ego lets her say the quiet parts out loud, but the real Libby? She's got receipts, range, and a righteous sense of purpose.If you're burnt out on algorithm-friendly “influencers,” meet a creator who actually stands for something. She doesn't flinch. She doesn't filter. And she damn well earned her platform.This is the most Jewish episode I've ever recorded. And yes, there will be guilt.RELATED LINKSLibby's Website: https://libbyambershayo.comInstagram: https://www.instagram.com/libbyambershayoTikTok: https://www.tiktok.com/@libbyambershayoLinkedIn: https://www.linkedin.com/in/libby-walkerSchmuckboys Podcast: https://jewishjournal.com/podcasts/schmuckboysForbes Feature: Modern Mrs. Maisel Vibes https://www.forbes.com/sites/joshweissMedium Profile: https://medium.com/@libbyambershayoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform.For guest suggestions or sponsorship, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What's on your mind? Let CX Passport know...Pharma and CX… not exactly two words you hear together often. But what happens when customer experience thinking meets healthcare? Silvi Haldipur has lived it. From personal experience to transforming patient, provider, and payer experiences at GSK and Merck, she's proving that empathy and data can coexist to truly save lives.5 Insights from This Episode • CX in pharma isn't impossible… it's essential. Silvi shares how she turned a deeply personal healthcare experience into her mission for better patient outcomes. • Beyond ads and emails… why support, not slogans, is what patients really need. • What pharma can learn from design thinking, ethnography, and on-the-ground empathy. • How “wraparound programs” simplify post-prescription chaos and actually improve outcomes. • The rise of the Chief Customer Experience Officer in pharma… and why it's long overdue.

Pharma is toxic and supplements are natural, right? Let's take a closer look. Get Take Daily HERE. LINKS AND RESOURCES: Watch Video Version Here: Rumble Video Bitchute Video Youtube Video-...

In this eye-opening episode, we take a closer look at two health concerns hiding in plain sight — the radiation risks of medical imaging in children and the hidden heavy metals lurking in popular protein supplements.First, we unpack the latest research on how diagnostic imaging — from CT scans to X-rays — can increase long-term cancer risks for kids. Then, we switch gears to the fitness world to ask: Is your protein shake as clean as you think it is? You might be surprised by what recent lab tests have found.www.georgebatista.com

On this Salcedo Storm Podcast: Chris and Sean talk shutdown and various impacts across Ameirca. Will Ameircans connect the dots about the dangers of all-powerful government? 

Why does it take ten years to bring a new medicine to market, and how can we reduce that number? In this episode of Talking Digital Industries, host Alex Chavez dives into the future of pharma and life sciences with Siobhan Fleming, Solution Owner for Digital Lab at Siemens; Andy Whytock, Pharma Expert at Siemens; and Sean Ruane, Principal Data Scientist at the Medicines Manufacturing Innovation Center. Discover how Siemens' Enterprise Recipe Management and AI-driven lab technologies are helping reduce development timelines, improve sustainability, and, in this case, to bring life-saving treatments to patients faster with the Digital Twin and AI.

Today, we're thrilled to talk to husband-and-wife dream team, Laurie & John Masiello. The Masiellos have been launching and scaling life science companies together since 1984. After merging their first company, Masy BioServices, with a North Carolina CDMO in 2021, the Masiellos struck again, forming Predictive Monitor in 2022. Their debut product, OverShield, combines IoT sensor technology with AI and data analysis to offer a powerful early warning system for controlled GMP chambers, from freezers to cold and stability rooms. The couple's mission centers around harnessing Pharma 4.0 technology to maximize equipment uptime, improve operational efficiency, and protect life-saving biopharmaceutical products.Hear Laurie & John walk us through their incredible shared journey and industry insights as they prepare to celebrate their 50th wedding anniversary.https://www.linkedin.com/company/predictive-monitor-llc/ Qualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über wacklige KI-Börsen, den neuen Plan für Siemens Healthineers und was diese Woche sonst noch wichtig wird. Außerdem geht es um Palantir, Nvidia, Meta, Microsoft, ASML, SAP, Infineon, Volkswagen, Siemens, Altair, Rumble, Northern Data, Merck & Co., Amgen, Regeneron Pharmaceuticals, Sanofi, AstraZeneca, Novo Nordisk, Eli Lilly, Robinhood und Walmart. Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

« La science et la santé, ce n'est pas une croyance. » – Pr David SmadjaDans cet extrait de Pharma minds, le Pr David Smadja revient sur l'un des épisodes les plus marquants de la pandémie : la controverse autour de l'hydroxychloroquine.Il raconte comment, en pleine crise, les médias et le grand public se sont mis à “croire” ou “ne pas croire” en un médicament, oubliant les fondements mêmes de la méthode scientifique.Une mise en garde lucide sur la désinformation et le rôle des médias, à écouter avant de découvrir l'épisode complet, dès demain, sur Pharma minds.Et pour les plus curieux, voici un sneak peek de ce que vous allez découvrir :

RFK Jr. announces Thursday's pharma agreement means Americans 'will lose 125 million pounds by this time next year.' But are cheaper, more widely available, weight loss drugs good for our country and our health?President Obama attempts to thread the needle between Zohran Mamdani's socialist win in New York City and Abigail Spanberger - ostensibly a 'moderate' - winning the governor's race in Virginia, claiming the two share a vision for American that Democrats must unite behind.

- Brighteon Broadcast News Introduction and AI Revolution Interview (0:10) - Collapse of Human Doctors and Pharmaceutical Industry (1:51) - Trump's Announcement and AI Replacements (11:06) - Economic Collapse and AI Solutions (12:06) - Replacing Congress with AI Agents (34:46) - AI Capabilities and Public Perception (52:28) - The Future of AI and Human Knowledge (1:23:58) - Psychological Barriers and Humility in AI Interaction (1:25:23) - The Future of the Book Industry (1:28:17) - Customization and Personalization in AI (1:35:16) - Advancements in AI and Human Cognition (1:36:27) - Investing in Personal Growth and Skills (1:40:16) - Decentralization and Privacy in AI (1:48:27) - The Role of AI in Personal and Professional Development (1:57:17) - The Future of AI and Robotics (2:07:23) - The Global Race in AI and Technological Advancements (2:10:21) - The Impact of AI on Employment and Society (2:18:24) For more updates, visit: http://www.brighteon.com/channel/hrreport  NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

Today The Chicks talk about everything from a Big Pharma exec collapsing during Trump's presser in the Oval Office to Kennedy's bold plan to cut Congress's pay during a shutdown. Meanwhile, Pelosi's retirement, Rand Paul's defiance, and MTG's throwbacks bring the heat.Plus: Tucker's Fuentes backlash, Islam's spread across Texas and NYC, and Gen Z's disturbing defense of socialist Rep. Mamdani. This episode covers all the insanity — from “fat privilege” to fake ICE stories, liberal TikTok meltdowns, and a viral reporter trying to shame Sydney Sweeney.SUPPORT OUR SPONSORS TO SUPPORT OUR SHOW!Become a premium member of the Angel Guild at https://Angel.com/Chicks to stream YoungDavid today and get two free tickets to see David in theaters this Christmas.Take advantage of Prolon's limited-time offer—get 15% off sitewide plus a $40 bonus gift whenyou subscribe to their 5-Day Program at https://Prolonlife.com/CHICKSNourish your hair, skin, and nails with HealthyCell's Vibrant Hair, Skin & Nails—get 20% off your first order at https://HealthyCell.com/CHICKS with promo code CHICKS.Whatever fall throws at you, make sure you're prepared—visit https://ReadyWise.com and use codeCHICKS10 for 10% off your order today!

Unfortunately, staffing shortages as a result of the government shutdown will affect SeaTac airport. Trump announced a new deal with pharma companies to reduce the price of weight loss drugs. // Seattle Indivisible calls for boycott of Microsoft Game Pass for not condemning a meme it didn’t create. // Washington classrooms are increasingly using AI.

In this episode, Dr. Paul Wheatley-Price chats with Dr. Bettina Hamelin, President & CEO of Innovative Medicines Canada (IMC) - the national association representing the voice of Canada's innovative pharmaceutical industry. They talk about what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug approval process in Canada. Learn more about Innovative Medicines Canada at https://innovativemedicines.ca/

Broadcasting from the Convene in midtown Manhattan, managing editor Jack O'Brien hosts the morning keynote session with Reddit's Jess Calef and R/nursing moderator Meg Dunning from the 2025 MM+M Media Summit.The pair underscore why the 20-year-old social media platform is having a moment among the medical marketing community and how health brands can maximize their ad dollars there. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A wide-ranging selection of tech companies, from drone software to med-tech have today been announced among the winners of the inaugural North-South Business Cooperation Awards, a €500,000 programme launched by the Stelios Philanthropic Foundation to celebrate cross-border entrepreneurship on the island of Ireland. The Awards, which culminated in a high-profile ceremony at Castle Leslie Estate, Co. Monaghan, saw a total of nine entrepreneurs and entrepreneur businesses in partnership, recognised for their outstanding achievements in building businesses that bridge communities in Northern Ireland and the Republic of Ireland. The Awards attracted a large volume of entries from across the island, with businesses demonstrating genuine cross-border collaboration and trade. Eligible companies were required to show a meaningful presence in both jurisdictions while also meeting minimum thresholds for turnover and employment. The result was a highly competitive field that showcased the strength and diversity of entrepreneurship operating across the island of Ireland. North-South Business Cooperation Awards A total of €500,000 in cash prizes was awarded: one Gold Award of €150,000, two Silver Awards of €100,000 each, and six Bronze Awards of €25,000 each. Partnering with Galway-based chocolatier, Grá Chocolates, Northern Irish tech platform needi took home a Silver Award. The female-founded service, created by co-founders Steph Scholes and Louise Doyle to connect businesses with local, independent vendors using AI technology and human curation, was set up in Armagh in 2020. Renewable energy solutions firm Acel Energy also received a Silver Award. The Monaghan-based company designs and implements solar tech, battery-storage and demand-management systems for commercial clients, often under co-ownership or Power Purchase Agreement models. Among the Bronze Award winners, med-tech companies saw huge success through cross-border partnered entries, with fertility clinics OvaScan Fertility Ultrasound (Dublin) and New Beginnings Scan (Strabane), which each combine advanced ultrasound technology with specialist expertise, taking home prizes through a joint entry. Súil Pharma, a Galway med-tech company developing novel therapies specialising in vision and hearing diseases, and Medinect Ophtho, a Belfast service provider delivering high-quality pre-clinic services, also joined forces to each take home a Bronze Award. Rounding off the joint entries, Subterranean Software, specialising in drone and embedded systems for constrained environments, and Good Friday Robotics, which develops advanced drone robotics for hazardous environments, were each also awarded a Bronze prize. Other Bronze winners in tech included Cotter Agritech, which develops precision livestock health tools, enabling selective treatment of livestock to reduce chemical usage and improve sustainability, and Arcus Cleaning Systems, an industrial hygiene and automated cleaning solution provider. Sir Stelios Haji-Ioannou, creator and owner of the easy family of brands - including easyJet.com, easyHotel.com and many others (see www.easy.com and www.easyHistory.info), and founder and president of the Stelios Philanthropic Foundation (see stelios.foundation and stelios.ie) - personally presented the awards and met the finalists at the ceremony. Speaking at an event announcing the winners, Sir Stelios Haji-Ioannou, said: "This is a proud day for entrepreneurship on the island of Ireland. The winners we honour today show that when determination, innovation and creativity meet, borders become bridges. These entrepreneurs are not only building successful businesses - they are proving that collaboration across communities leads to prosperity for all. They are creating jobs, delivering services and setting an example for the next generation of entrepreneurs. I hope that their success today will encourage even more entrepreneurs to think ambitiously, work collaboratively, and see the entire isl...

When the system kills a $2.4 million study on Black maternal health with one Friday afternoon email, the message is loud and clear: stop asking questions that make power uncomfortable. Dr. Jaime Slaughter-Acey, an epidemiologist at UNC, built a groundbreaking project called LIFE-2 to uncover how racism and stress shape the biology of pregnancy. It was science rooted in community, humanity, and truth. Then NIH pulled the plug, calling her work “DEI.” Jaime didn't quit. She fought back, turning her grief into art and her outrage into action. This episode is about the cost of integrity, the politics of science, and what happens when researchers refuse to stay silent.RELATED LINKS• The Guardian article• NIH Grant• Jaime's LinkedIn Post• Jaime's Website• Faculty PageFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Black Women's Health, Dr. Rahman will discuss why we need more research, not more menopause products,Currently;Pharma tells women : "Here's a prescription solution."Wellness tells women: "Here's a supplement solution"'Food Industry: "Here's a menopause bar with collagen and adaptogens for $29.99."The question:- If symptoms are due to declining estrogen levels, why womens' symptoms present so differently.The problem :- For the global billion dollar menopause market, it is important to keep women "in need of their services and products".- Women get products but get few answers with limited care and limited research Bottom line:The menopause industry has grown faster than menopause research.

Earnings are filtering in, and companies are seeing a tale of two very different consumers. The group raising concerns about their customer base, and the names not seeing any slowdown. Plus Novo and Eli Lilly nearing a deal with the White house to lower obesity drug prices. What it means for the space, and how it could change medicare coverage of the weight loss drugs.Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Shares of generics drugmaker Teva Pharma jumping double digits after earnings. Its CEO breaks down the impact of tariffs and price negotiations on margins. Then an inside look at Aramco's AI strategy, live from its headquarters in Saudi Arabia. Plus, the Supreme Court hears challenges against the Trump administration's tariff policies. A live report from outside the court room. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

How many MM+M Podcast listeners are currently growing mustaches?This is our first episode of November, also known as Movember, the annual monthlong event raising awareness of men's health.The most well-known aspect of Movember is growing a mustache in a bid to elevate the profile of some highly stigmatized health topics like prostate cancer, infertility or behavioral issues.Yet for all the progress achieved and charity dollars raised, the Movember Foundation is always looking for more brands to step forward and support the cause.On this week's episode, managing editor Jack O'Brien speaks with BBD Perfect Storm Health managing partner Nick Dutnall about how brands need to step up their efforts around men's health – not only during Movember but throughout the rest of the year.Plus, we have a few live hits from the 2025 MM+M Media Summit.Music: “Deep Reflection” by DP and Triple Scoop Music. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Bonus Episode for Nov. 4. The weight-loss-drug arms race is only heating up, as Novo Nordisk attempts to snatch drugmaker Metsera away from Pfizer. But can either company compete with Zepbound seller Eli Lilly? WSJ reporter Peter Loftus discusses what earnings from Big Pharma, including AbbVie, Bristol Myers Squibb and Merck, say about the future of the industry and how companies are responding to President Trump's drug-pricing plans, including TrumpRx. WSJ Heard on the Street columnist David Wainer hosts this special bonus episode of What's News in Earnings, where we dig into companies' earnings reports and analyst calls to find out what's going on under the hood of the American economy. Sign up for the WSJ's free Markets A.M. newsletter. Further Reading: Novo Nordisk Sweetens Offer for Metsera - WSJ Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk The Day Pharma's Weight-Loss Gold Rush Intensified Pfizer Profit Falls Amid Lower Covid-19 Drug Demand Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera Novo Nordisk to Shake Up Board After Obesity-Market Challenges Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings AbbVie Lifts Profit Outlook as Sales Rise Bristol Myers Squibb Profit Soars, Raises Revenue Guidance Merck Profit Rises on Strong Keytruda Demand GSK Lifts Guidance After Specialty Medicines Boost Sales Novartis Expects to Ride Out Patent Losses With Sales, Profit Growth Ahead Biogen Cuts Full-Year Earnings Guidance, Despite Third-Quarter Profit Rise J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains Learn more about your ad choices. Visit megaphone.fm/adchoices

EPISODE DESCRIPTIONAllison Applebaum was supposed to become a concert pianist. She chose ballet instead. Then 9/11 hit, and she ran straight into a psych ward—on purpose. What followed was one of the most quietly revolutionary acts in modern medicine: founding the country's first mental health clinic for caregivers. Because the system had decided that if you love someone dying, you don't get care. You get to wait in the hallway.She's a clinical psychologist. A former dancer. A daughter who sat next to her dad—legendary arranger of Stand By Me—through every ER visit, hallway wait, and impossible choice. Now she's training hospitals across the country to finally treat caregivers like patients. With names. With needs. With billing codes.We talked about music, grief, psycho-oncology, the real cost of invisible labor, and why no one gives a shit about the person driving you to chemo. This one's for the ones in the waiting room.RELATED LINKSAllisonApplebaum.comStand By Me – The BookLinkedInInstagramThe Elbaum Family Center for Caregiving at Mount SinaiFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Subscribe to the video podcast: https://www.youtube.com/@LiveHolPlus/podcastsMental health is not a simple checklist, it is a whole body story. In this hol+ episode, Dr. Taz sits down with Dr. James Greenblatt, a pioneer of integrative and nutritional psychiatry, to rethink how we approach depression, anxiety, ADHD, and eating disorders through labs, nutrients, hormones, and personalized care.Together, they unpack why so much suffering persists despite more medications, how root cause testing changes outcomes, and why simple shifts like correcting vitamin D, B12, iron, thyroid, zinc, and omega 3 can transform mood and resilience. They also explore nutrigenomics for precision dosing, the real limits of 10 minute telehealth med checks, and where tools like ketamine, psychedelics, and lithium orotate fit only after foundations are in place.From practical lab targets and cost effective protocols to the crossroads of food, sleep, screens, and ADHD, this conversation invites us to see mental health not as a diagnosis to medicate, but as a system to understand and support.Dr. Taz and Dr. Greenblatt discuss:The gap between symptom focused care and root cause testingKey labs for mood, vitamin D, B12, iron, thyroid, hormonesWhy micronutrients come first for eating disordersMTHFR, methylfolate, glutathione, and antidepressant responseNutrigenomics for personalized vitamin and mineral dosingThe risks of quick med stacking and 10 minute checksWhere ketamine, psychedelics, and lithium orotate may help, and when they do notADHD, ultra processed foods, sugary drinks, sleep, and screen timeAbout Dr. James Greenblatt, MDDr. James Greenblatt, MD is a board certified psychiatrist and a pioneer of integrative and nutritional psychiatry. For more than three decades he has treated patients with ADHD, depression, anxiety, and eating disorders using personalized protocols that combine conventional care with targeted nutrients and lab guided precision. He is the author of multiple books including Finally Focused and the upcoming Finally Hopeful.Connect further to Hol+ at https://holplus.co/- Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+.Get your copy of The Hormone Shift: Balance Your Body and Thrive Through Midlife and MenopauseStay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram:https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Follow Dr. James Greenblatt MD: Website: https://jamesgreenblattmd.com Platform: https://PsychiatryRedefined.org Instagram: https://instagram.com/psychiatry_redefinedDon't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+00:00 Introduction, testing gap and the B12 tragedy01:31 Pharma model and 10 minute med checks02:37 Framing the crisis and why patients feel stuck05:49 How psychiatry arrived at symptom based meds07:29 What to test, hormones and core nutrients10:49 The Whole Body Map explained12:39 Vitamin D, B12, iron, thyroid, practical targets17:52 Why meds fail without nutrition18:23 Eating disorders, zinc, omega 3, methylfolate24:33 MTHFR, folate, and glutathione26:34 Nutrigenomics and personalized dosing29:51 Ketamine and psychedelics, proceed with caution32:26 Lithium orotate, irritability and dementia research38:57 Polypharmacy, slowing down, doing the work43:21 ADHD, diet, sleep, screens, lifestyle links46:28 Where to learn more, resources, closing (00:00) - Chapter 1 (00:00) - Introduction, testing gap and the B12 tragedy (01:31) - Pharma model and 10 minute med checks (02:37) - Framing the crisis and why patients feel stuck (05:49) - How psychiatry arrived at symptom based meds (07:29) - What to test, hormones and core nutrients (10:49) - The Whole Body Map explained (12:39) - Vitamin D, B12, iron, thyroid, practical targets (17:52) - Why meds fail without nutrition (18:23) - Eating disorders, zinc, omega 3, methylfolate (24:33) - MTHFR, folate, and glutathione (26:34) - Nutrigenomics and personalized dosing (29:51) - Ketamine and psychedelics, proceed with caution (32:26) - Lithium orotate, irritability and dementia research (38:57) - Polypharmacy, slowing down, doing the work (43:21) - ADHD, diet, sleep, screens, lifestyle links (46:28) - Where to learn more, resources, closing

Tuesday Noember 4, 2025 A Pharma Giant is Looting the Pentagon

Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access.  A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it's the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbursement that pushes clinicians toward concierge and direct primary care, and payer tactics that encourage consolidation rather than capacity.Kaufman and Helppie then get specific about the economics. Medicaid rates that barely cover overhead lead practices to cap panels, while insurers play separate groups against each other until they merge, gaining leverage but not necessarily improving availability. Primary care, which should function like a straightforward retail experience, is instead forced through insurance mechanics that add friction to simple, high-value services. The result is predictable: over 40 percent of ER visits come from Medicaid patients who couldn't access timely outpatient care, and the most vulnerable pay the highest price in avoidable emergencies.Their conversation wrestles with the big numbers and the real trade offs. Ten percent of patients drive more than 80 percent of spending across Medicare and commercial plans. Pharma's incentives to expand lifelong demand clash with insurers' incentives to deny care. The federal government, the largest health benefits organization in the world, changes leadership every few years, making long-term workforce planning and access expansion difficult. They outline pragmatic moves that can help now: secure continuity with direct primary care or concierge if possible, build a relationship with a PCP who can open specialist doors, and for complex care, shop outcomes rather than prices.If you've felt the squeeze—months-long waits, denials, or a scramble for appointments—this conversation gives language, data, and practical options. Listen to understand why access is collapsing, what levers could ease the pressure, and how to protect your path to timely, high-quality care today. If the ideas resonate, follow and share, and leave a review with your own access story—what worked, what didn't, and what needs to change next.Support the showEngage the conversation on Substack at The Common Bridge!

PODCAST LAS NOTICIAS CON CALLE DE 3 DE NOVIEMBRE 2025 -  NO DE TRUMP A LA ESTADIDAD para PR - Truth TRUMP echa pa atrás y ahora dice que quiere pagar SNAP y cupones - Truth Sigue siendo delito asesinato de mujeres, solo hay polémica sobre se llama feminicidio o no - Primera Hora Demotion o no para secretario de Agricultura - El Nuevo Día Baja a votación ley para eliminar escoltas a futuros gobernadores Gobernadora vuelve a nombrar otro comité ahora para impuesto del inventario - El Nuevo DíaPresupuesto ha sido ideológico no ha sido real austeridad - El Nuevo DíaGobernadora dice que su logro y su meta es … CESCO DIGITAL, pero en otras agencias - El Nuevo Día Negocian para contrato de Gas Natural con la Junta y la gobernadora - El Nuevo Día Ya Energiza nos dice que no va a ser más caro el costo de su planta y que van para finales de la década- El Nuevo Día ¿Vale la pena meterle tanto dinero a incentivar big Pharma cuando ya no crea los empleos que antes? - Cuarto Poder Niño tira petardo mientras camión echaba gasolina, lo buscan a él y a su madre - WUNORecortan dinero para cuidado histórico - El Nuevo día Familia de la gobernadora dice que no hay investigación sobre casa de la Parguera - El NuevoDía Turista de Chicago alega que tres mujeres le echaron algo en bebida para robarle Rolex y otras pertenencias - Primera HoraLa contralora pide poderes - El Nuevo DíaHarán pruebas nucleares, sin hacer explosiones dicen jefe de energía federal - NyT Trump dice no a tomahawks para Ucrania, por ahora, aunque Dpto de Guerra había dicho que sí - Reuters Trump considera meterle ejército a Nigeria por genocidio de cristianos - WSJTrump insiste en acabar con el filibusterismo para reabrir el gobierno federal  - Truth Llegó el momento de las arañitas a Martins BBQ! Pide el mejor y más sabroso pollo asado a la vara de Puerto Rico en combo con arañitas de plátano…fresquecitas, acabaditas de hacer en Martin 's BBQ, Justo como te gusta!  Entregando con Ubereats y Doordash en tiendas participantes,Pide tus arañitas en MMMMartins BBQ comida fresca, hecha todos los dias.Asado, Jugoso, Sabroso..hoy voy pa Martins bbqIncluye auspicio 

Host: Annik Sobing Guest: Elizabeth Lomax, Trade Compliance Consultant (Pharma Specialist) Published: October 23 Length: ~25 minutes Presented by: Global Training Center In this Simply Trade News Roundup, host Annik sits down with leading trade compliance consultant Elizabeth Lomax to tackle the timely and turbulent world of the pharmaceutical supply chain. With shifting trade rules, tariff threats, and regulatory uncertainty dominating industry headlines, Elizabeth shares real-world insight into how manufacturers—especially smaller innovators—are navigating anxiety, adapting compliance processes, and preparing for possible disruption. The conversation breaks down executive orders, HTS code strategy, the impact of de minimis changes, and the crucial role of documentation. Together, they address how ongoing tariff debates, differential exemption policies, and rapid-fire policy shifts are shaping both immediate risk and long-term strategy for pharmaceutical companies of all sizes. What You'll Learn in This Episode The state of pharma tariffs, exemptions, and compliance in 2025 “Big Pharma” vs. smaller innovators—who the rules favor, and why How executive orders and truth social posts differ from enforceable policy HTS code strategies, annex exemptions, and documentation best practices How tariffs and cash flow risks hit small businesses hardest What de minimis no longer means for the industry in practice The impact (and irony) of U.S. policy on drug pricing, shortages, and innovation Why ACE reports and robust recordkeeping are make-or-break for compliance How to model tariff scenarios and strengthen your playbook—no matter what comes next Key Takeaways “Tariff anxiety” is real—prepare processes, but don't panic over shifting headlines Accurate classification, valuation, and country of origin are your best defense Small pharma faces unique hurdles when policy focuses on negotiation and volume Stay plugged in to new developments and keep your compliance documentation airtight Trade teams may need added resources or automation to keep pace with a volatile landscape ACE reporting, scenario modeling, and strategic partnerships can help mitigate future shocks Resources FDA Policy Updates ACE Reporting Guides Global Training Center's Three Pillars Course Credits Host: Annik Sobing Guest: Elizabeth Lomax Producer: Lalo Solorzano Subscribe & Follow New episodes every week. Presented by: Global Training Center — providing education, consulting, workshops, and compliance resources for trade professionals.

The healthcare marketing landscape is evolving fast — shaped by regulatory shifts, patient empowerment, and the rise of digital health marketplaces. In this episode of The Top Line, sponsored by Havas Media Network, host Chris Hayden sits down with Holly Dunn, Managing Partner of Performance at Havas Media Network, to explore how pharma brands can redefine patient engagement for a more connected, equitable future. Dunn explains how first-party data, AI-driven intent signals, and curated health marketplaces are enabling more compliant, transparent, and human-centered campaigns. She also discusses the growing role of healthcare creators, the fight against misinformation, and strategies to ensure high-quality, privacy-safe engagement across the patient journey. If you’re in pharma or biotech marketing, this conversation offers critical insight into how leading brands are building trust and equity in an increasingly complex environment.See omnystudio.com/listener for privacy information.

Tech earnings, political pressure on drugmakers, and the ongoing shutdown shape the week ahead. AI remains the star topic as investors hunt for clarity from the Fed and jobs data delays.➡️ Just a quick reminder, Capital Markets Quickie is brought to you by AMF Capital AG, Asset Management Frankfurt, your leading provider for individual investment solutions and mutual funds. Visit https://www.amf-capital.de for more information.>>> Make sure to check out my newsletter "Cela's Weekly Insights":https://endritcela.com/newsletter/>>> You can subscribe here to our YouTube Channel “MVP – Main Value Partners”:https://www.youtube.com/@MainValue>>> Visit my website for more information:http://www.endritcela.com>>> Follow me on LinkedIn:https://www.linkedin.com/in/endrit-cela/>>> Follow me on Instagram:https://www.instagram.com/endritcela_official/Disclaimer for "Capital Markets Quickie" Podcast:The views and opinions expressed on this podcast are based on information available at the time of recording and reflect the personal perspectives of the host. They do not represent the viewpoints of any other projects, cooperations, or affiliations the host may be involved in. "Capital Markets Quickie" does not offer financial advice. Before making any financial decisions, please conduct your own due diligence and consult with a financial advisor.

Amazon bekommt einen $38 Mrd. Auftrag von OpenAi, was den Nadsaq anfacht. Ansonsten ist die Tendenz trotz eines Mega-Deal im Pharmabereich und einer weiteren Annäherung zwischen China und den USA uneinheitlich. Kenvue wird für fast $50 Mrd. von Kimberly Clark übernommen. Letzte Woche kursierten Gerüchte, dass sich auch Moderna zum Verkauf aufgestellt hat. Die Aktionäre werden in Cash und Aktien angefunden. Was Quartalszahlen betrifft, hatte wir letzte Woche den Zenit der Meldungen. Es haben nicht nur ungewöhnlich viele Unternehmen die Ertragsziele geschlagen. 43% der Firmen, die sich zu den Aussichten äußerten, haben die Prognosen angehoben. Wir sehen für Q3 nun ein solides Gewinnwachstum von 10,7%, berichtet FactSet. Berkshire Hathaway konnte am Wochenende die Erwartungen ebenfalls übertreffen, mit der Aktie vor dem Opening freundlich. Im weiteren Wochenverlauf stehen erneut einige wichtige Tech-Ergebnisse an. Heute Abend meldet Palantir, gefolgt von AMD, Arista Networks, Super Micro, Shopify und Spotify am Dienstag. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Dr. Andrew Wakefield: What They Don't Want You to Know About Vaccines & AutismThis interview changed me forever. At dawn on the Sunshine Coast, I sat down with Dr. Andrew Wakefield - a surgeon who lost his career, reputation, and homeland for daring to ask medical questions others refused to consider. Decades ago, Wakefield became the original “cancelled” doctor, ostracised for listening to mothers and voicing concerns over what was happening to their children.What happened to Dr. Wakefield 25 years ago is happening again, as doctors today face backlash for questioning COVID narratives, vaccine mandates, and public health policy.What You'll DiscoverThe real story behind the MMR vaccine controversy and how powerful media figures targeted WakefieldWhy vaccine safety studies aren't conducted by the same standards as other pharmaceuticalsBombshell CDC whistleblower revelations featured in VaxxedHow COVID exposed medical industry corruption worldwideBobby Kennedy Jr. and the fight for true health reformsThe suppressed study on chronic disease rates in vaccinated vs. unvaccinated childrenWhy pharmaceutical giants double down on their mistakesPersonal StoryAt age 3, I had bacterial meningitis soon after my vaccines. My wife, Anna, endured 20 miscarriages - after getting a rubella shot before trying to conceive. Wakefield's insights explain why it matters.Wakefield isn't peddling conspiracy theories. He comes from six generations of doctors, trained at St. Mary's Hospital in London, fully immersed in conventional medicine until he listened to parents and followed the science, wherever it led.Key Topics CoveredThe gut-brain connection that mainstream medicine ignoresProven dietary interventions Big Pharma says “won't work”The revolving door between regulators and pharma corporationsLegal battles, censorship, and organized character attacksWhy listening to mothers changes livesRFK Jr's plans for future vaccine policyWakefield's new films documenting affected childrenWarningThis conversation will challenge you- and it should. Our children deserve truth, not comfortable lies.Notable Quotes"Film can touch millions, where a clinic only treats one.""COVID was the mistake that revealed everything.""Vaccine safety standards are actually LOWER for healthy children than for other drugs.""The parents were right. Inflammation was there. The medical authorities were wrong.""Pharma can't admit their failures- they double down instead.""The universe doesn't care about me. So get on with it.""Mothers know their children better than anyone else, especially better than pediatricians."ResourcesMust-watch films: Vaxxed, Vaxxed II: The People's Truth, Protocol-7, An Inconvenient StudyConnect: info@wakefieldmediagroup.com / wakefieldmediagroup.comOther Experts MentionedDr. Stephanie SeneffDr. Peter McCulloughDel BigtreeDr Bryan ArdisReal DisclaimerThis content is for educational purposes, not medical advice. Use your judgement. Do your own research. Ask questions. Trust your instincts.Call to ActionSubscribe if you want real truth. Like if you believe parents deserve answers. Comment with your story. Share before it...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today's focus is on a series of significant advancements that are poised to reshape the landscape of drug development, regulatory standards, and patient care.Eli Lilly has made remarkable strides with its dual-action obesity medications, Zepbound and Mounjaro. Despite being removed from the CVS formulary, these drugs have achieved exceptional sales figures, reaching $10 billion in a single quarter. This success can be attributed to Lilly's innovative direct-to-consumer sales strategy, which exemplifies how modern marketing approaches can overcome traditional market barriers. Additionally, Eli Lilly's partnership with Walmart to expand access to Zepbound through retail pharmacy pickups exemplifies a strategic approach to enhancing patient access to crucial medications. By leveraging Walmart's extensive retail network, this collaboration facilitates easier access to obesity treatments—a significant public health challenge—enhancing both patient convenience and broadening market reach for Lilly's products. These achievements not only highlight the potential of strategic marketing but also underscore a growing demand for effective obesity treatments within the pharmaceutical industry.In another exciting development, Alnylam Pharmaceuticals has reported impressive sales figures for Amvuttra, a treatment for transthyretin amyloid cardiomyopathy. Surpassing analysts' expectations, this success signals a growing market for treatments targeting rare diseases and emphasizes the importance of strategic market expansion to reach underserved patient populations.Meanwhile, Bristol Myers Squibb's anticipated schizophrenia treatment, Cobenfy, has experienced a lukewarm market entry. While meeting initial expectations in its first year, it has yet to create the breakthrough impact investors anticipated. This situation highlights the challenges even well-hyped pharmaceuticals face upon launch and underscores the need for continuous strategic planning to ensure market penetration and sustained growth.A surprising development in mergers and acquisitions comes from Novo Nordisk's $6.5 billion counteroffer to acquire Metsera, an obesity biotech initially targeted by Pfizer. This aggressive move reflects intense competition in the obesity drug market and illustrates the high stakes involved in acquiring promising biotech assets that could potentially transform treatment paradigms for chronic conditions like obesity.The vaccine industry is navigating its own set of challenges with declining sales across the board. However, Merck's adult pneumococcal vaccine Capvaxive has shown promising initial sales figures. As the first pneumococcal vaccine specifically designed for adults, Capvaxive indicates a potential niche market that Merck could successfully capture.On the regulatory front, significant measures are being taken by the FDA to boost biosimilar availability against drug pricing pressures. New draft guidance aims to eliminate clinical testing requirements for biosimilars and categorize all approved biosimilars as "interchangeable." This initiative could significantly reduce biologic medicine costs post-patent expiration and increase competition in the market, potentially making essential medications more accessible to patients. Additionally, the FDA is proposing streamlined biosimilar approval pathways aimed at reducing overall bio-drug costs—a welcome move reflecting concerted efforts to make essential medications more affordable and accessible globally.Argenx has reported positive trial results for Vyvgart in treating generalized myasthenia gravis (gMG), highlighting its commitment to addressing unmet needs within this patient population. These findings could expand treatment options for gMG patients who have been previously overlooked in thSupport the show

Apple & Amazon the latest big tech names to report results. The headlines from the company conference calls, and what top tech analyst Gene Munster sees in store for the group. Plus Eli Lilly jumping as its obesity drug sales soar. How the company is moving the needle in the weight loss wars, and the other pharma stocks moving on potential M&A action.Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The traditional path to patients is being rewritten. As affordability pressures rise and patient expectations shift, life sciences companies are rethinking the middle — moving beyond payers, providers, and pharmacies to create direct, digital pathways that meet patients where they are.In this episode, host Adrea Cope is joined by Colleen Ferlotti and Rupa Mehta to unpack the rapid rise of Direct-to-Patient (DTP) models: what's fueling the shift, how leaders are navigating regulatory and operational complexity, and why success depends on designing with both discipline and empathy.To learn more about how we can help your team navigate these changing landscapes, please reach out to Mike.Zapiec@vynamic.com Podcast Tags: healthcare, life sciences, life sciences marketing, direct to patient, patient centricity, digital health  Source Links: Triangle Insights Group (August 2025). The Direct-to-Patient Channel in Pharma: A Practical Guide to Protect GTN, Expand Access, and Improve Patient Experience. Panel – Adrea Cope, Colleen Ferlotti, Rupa Mehta Research & Production – Adrea Cope, Colleen Ferlotti, Rupa Mehta, Peter Svalbe, Mike Zapiec Recording & Editing – Mike Liberto For additional discussion, please contact us at TrendingHealth.com.  

Remii “Rock Steady” is a third-generation chemist, cannabis process engineer, and pharmaceutical cannabinoid developer in the cannabis and hemp industry.Expect to learn about the endocannabinoid science (how THCA becomes Δ9 THC, why CBGA is the “alpha,” and what β-caryophyllene really does), pharma-grade production (GMP cleanrooms, dronabinol/API validation, and why documentation rules everything), and the industry's crossroads (THCA-hemp loopholes, rescheduling vs. descheduling, and safe vs. risky conversions like HHC/THCP).Do you support descheduling cannabis to protect craft operators?Follow Remy “Rock Steady”:Instagram: @_rock_steady._YouTube: Rock Steadyy's WorldWebsite:  @rocksteadysworld 

Kailera Therapeutics raised $600 million in a recent funding round for two new drugs to manage obesity.

PODCAST LAS NOTICIAS CON CALLE DE 29 DE OCTUBRE DE 2025 - Advierten a JGO contra pagar los cupones, tienen los juegos del hambre - Cuarto Poder JGo descarta usar fondo de emergencias para los cupones - Cuarto Poder Rumores de big Pharma invertirá en PR, mientras Lilly anuncia partnership con Nvidia - CNBC Federales arrestan por corrupción en Hacienda - El Nuevo Día Harán 27 salones de seguridad para desastres en PR - El Nuevo Día No confirman designada comisionada de seguros - El Nuevo Día Pablo José recomienda unirse a demanda contra Trump para que pague los cupones - Cuarto Poder AEE dice que LUMA quiere que le pase dinero que LUMA no cobra - El Vocero Gobernadora dice que vetaría medida de Impuesto de Inventario si no encuentran  - El Vocero Buscan reducir ganancias de capital a los locales como al os de fuera, pero entonces dicen que esto es darle incentivos a los ricos de fuera y a los de aquí - El Vocero 70 mil contadores no se han arreglado y son estimados - El Vocero AEE tiene déficit de 600 millones - El Vocero Difícil para ICE conseguir empleados fit para trabajar allí a pesar de montones de solicitudes - Axios JGo no se solidariza con DACO ni opina de demanda contra LUMA por enseres - El Vocero Supuestamente hay tres empresas interesadas en venir a trabajar para sustituir a LUMA - El Vocero Más vistas y se atrasa el proceso de Antonieshka por asesinato de Gabriela Nicole - Cuarto Poder Destrucción de Jamaica y ahora entró a Cuba categoría 3 - NWSLogran acuerdo comercial Trump y Corea del Sur, mañana se reúne con Xi el presidente Trump - CNNVan de PR a Jamaica con ayuda médica - Primera Hora Advierten grid energético de USA está bien atrás y hay que meterle turbo para manufactura - Axios Siempre innovando y con los mejores beneficios, MCS PersonalDirecto te ofrece cubiertas accesibles para que cuides de tu salud y la de los tuyos.Con una amplia red de proveedores de más de 15,000 médicos de libre selección.Reembolso de hasta $40 mensuales por membresía a un gimnasio o por un entrenadorpersonal debidamente certificado. Asistencia en el hogar para servicios de cerrajería,plomería y electricidad de hasta $350 por evento hasta 4 veces al año.¡Únete HOY a la gran familia de MCS!¡Salud que completa tu vida! Llama al 787.945.1259 y oriéntate.Endoso pagadoIncluyendo auspicio 

Do you ever feel like you're doing “all the right things” but not seeing real results?In this episode, Greg & Rachel Denning challenge the sacred cows of school, pharma, and religion—not to burn it all down, but to help you keep what serves your family and release what doesn't. You'll learn how to shift from transactional box-checking to transformational growth, so your kids develop inner authority, critical thinking, and personal responsibility.Big idea: You can honor helpful traditions and raise kids who can question wisely, choose higher standards, and own their outcomes—in education, health, spirituality, and life.What we cover:• Why outsourcing your child's education, spirituality, or health stalls growth• How to “keep the good” in institutions while ditching deadweight rules• The path from conformity to character—raising autodidacts who learn for life• Practical habits that create palpable progress in mind, body, spirit, and family cultureKey Takeaways✅ Transactional → Transformational: Results > routines.✅ Inner Authority: Teach kids to think, not just comply.✅ Keep & Elevate: Honor useful rules; raise the standard at home.✅ Autodidact Mindset: Light the fire, don't fill the bucket.✅ Measure Progress: If outcomes don't improve, change the method.Chapters00:00 Challenging Sacred Cows02:32 The Importance of Questioning Traditions04:58 Individual Authority and Personal Growth07:22 Outsourcing Education and Spirituality10:29 Transformational vs. Transactional Experiences13:05 The Role of Institutions in Personal Development15:25 The Quest for Holistic Progress18:27 Facing Fears and Embracing Truth21:28 The Labyrinth of Personal Growth28:40 Facing Fears and Doubts29:32 The Nature of True Education30:51 The Challenge of Conformity32:22 Resisting Authority Thoughtfully33:41 The Importance of Imagination35:03 Faith at the Edge of the Abyss36:18 Questioning Conventional Wisdom38:01 Learning from Others' Experiences40:41 Walking the Labyrinth of Faith41:48 Understanding Meta Truths44:10 The Concept of the Fringe46:44 Navigating the Lower and Upper Fringe49:03 Living Beyond Conformity50:31 Transformational Living Beyond the BasicsMemorable Quotes

When Procter & Gamble asked Atsushi Kitamura to move from finance analysis into running a manufacturing plant, he didn't hesitate. “They always give me next challenge to stretch me,” he tells us. Managing one of P&G's large diaper plants in Japan forced him to apply finance in real-time operations—a proving ground that shaped his comfort with change and appetite for transformation.That readiness carried him from consumer goods to logistics, restaurants, and electronics before arriving at Astellas Pharma, where the stakes are now measured in science and strategy. When he joined in 2023, Astellas had just completed a $6 billion acquisition that shifted it from a net-cash to a net-debt position. Hired to “put financial disciplines and make the balance sheet stronger,” Kitamura tells us he views the moment as a “transformative timing” for the company. Loss of exclusivity on a prostate-cancer drug representing “more than 40 percent of our revenues” demands reinvention.His three-part playbook focuses on growing core brands, investing in science creation, and executing what he calls “sustainable margin transformations.” The approach has begun to pay off—“top line 19 percent, profit 40 percent,” he tells us—signaling a finance organization in renewal.Now he's turning to technology to sustain that momentum. Describing the shift from RPA to “agentic AI,” Kitamura explains, “I just ask agent AI to do that booking.” He calls it a tipping point that will “change significantly the way how we work.”Still, he adds, leadership begins with listening. “Don't pretend I know everything,” he tells us. For Kitamura, finance transformation starts not with machines or metrics—but with humility.

David Murphy, Economics and Public Affairs Editor speaks to Wilbur Ross, former US Commerce Secretary, about the future of the Irish pharmaceutical industry.

- Improvements in Sensor Dot News and AI Engine (0:10) - Demonstration of AI-Generated News Content (3:16) - Development and Impact of Brighteon.ai (6:55) - Introduction of Grokipedia and Naturalpedia (9:46) - Challenges and Future Plans for AI Projects (14:03) - Launch of Vaccine Forensics Website (24:24) - Features and Capabilities of Vaccine Forensics (31:36) - Importance of Independent Media and AI Engines (44:25) - Special Reports on UBI and Food Riots (57:35) - Food Stamp Program and Its Impact on Society (1:20:38) - Political Benefits and Potential Violence (1:25:05) - Economic and Social Consequences (1:33:51) - Preparation and Safety Measures (1:38:28) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

EPISODE DESCRIPTIONRebecca V. Nellis never meant to run a nonprofit. She just never left. Twenty years later, she's still helming Cancer and Careers after a Craigslist maternity-leave temp job turned into a lifelong mission.In this 60-minute doubleheader, we cover everything from theater nerdom and improv rules for surviving bureaucracy, to hanging up on Jon Bon Jovi, to navigating cancer while working—or working while surviving cancer. Same thing.Rebecca's path is part Second City, part Prague hostel, part Upper East Side grant writer, and somehow all of that makes perfect sense. She breaks down how theater kids become nonprofit lifers, how “sample sale feminism” helped shape a cancer rights org, and how you know when the work is finally worth staying for.Also: Cleavon Little. Tap Dance Kid. 42 countries. And one extremely awkward moment involving a room full of women's handbags and one very confused Matthew.If you've ever had to hide your diagnosis to keep a job—or wanted to burn the whole HR system down—this one's for you.RELATED LINKSCancer and CareersRebecca Nellis on LinkedIn2024 Cancer and Careers Research ReportWorking with Cancer Pledge (Publicis)CEW FoundationI'm Not Rappaport – Broadway InfoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship opportunities, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's time to build your family's future on a foundation of true health and freedom. Join us at Future Foundations—because your future generations deserve the best start to the mission that will outlive us… Check it out here. Use code FREEDOM25 for 25% off! Whether you're looking for tinctures, topicals or teas or a deeper connection to your INNATE healing capacity, Noble Task Homestead is here to serve you. Join the movement. Visit NobleTaskHomestead.com/noblestan today and enjoy a 10% discount on your order. San Diego area residents, take advantage of our special New Patient offer exclusively for podcast listeners here. We can't wait to experience miracles with you! Welcome to another powerful episode of the Future Generations Podcast! Host Dr. Stanton Hom sits down with Mark Groves, a human connection specialist with a fascinating journey from pharmaceutical sales to relationship expert and social commentator. This episode is a must-watch for individuals struggling with personal relationships, healthcare professionals seeking deeper insights into emotional health, people interested in understanding social manipulation, those experiencing technology-induced stress, and anyone seeking personal growth and self-awareness. Delving deep into personal healing, societal manipulation, emotional intelligence, and the complex landscape of human behavior during challenging times, this conversation offers transformative insights for viewers looking to understand the intricate dynamics of human connection in our modern world. Highlights: "I was really good at talking about everything but my feelings." "I found myself more connected to myself than ever, even though I was single." "So much of inflammation was caused by emotional dysregulation and trauma." "I felt like I was living in an upside-down world." "Stating the facts of informed consent is considered an attack." Timestamps: 00:01 - Podcast Introduction and Guest Welcome 00:57 - Mark's Journey from Pharmaceutical Sales to Human Connection Specialist 03:58 - Insights into COVID-19 Pandemic Narratives 12:07 - The Psychological Impact of Technology and Social Media 22:49 - Attention as Currency in Digital Platforms 26:47 - Exploring Solutions for Personal Healing and Connection 29:37 - Building Community and Breaking Down Social Divisions 36:27 - Practical Strategies for Technology Detox 45:13 - The Importance of Personal Values and Self-Alignment 53:29 - The Power of Personal Responsibility and Transformation Resources: Remember to Rate, Review, and Subscribe on iTunes and Follow us on Spotify! Learn more about Dr. Stanton Hom on: Instagram: https://www.instagram.com/drstantonhom Website: https://futuregenerationssd.com/ Podcast Website: https://thefuturegen.com Twitter: https://twitter.com/drstantonhom LinkedIn: https://www.linkedin.com/in/stanhomdc Stay Connected with the Future Generations Podcast: Instagram: https://www.instagram.com/futuregenpodcast Facebook: https://www.facebook.com/futuregenpodcast/ Links: https://www.thehivemethod.co/ https://www.instagram.com/thehivemethod.co About: Human Connection Specialist, Speaker, Author, Coach, Podcast Host and founder of Create The Love. Born with an innate curiosity and a hunger for truth, Mark's journey of self-discovery and personal liberation has led him to spend the last decade coaching and inspiring millions worldwide to create the life and love they desire. Through his candid but compassionate, no-BS guidance, Mark has helped empower countless individuals, teams, and companies to step into their most authentic, effective, and loving selves, transform how they relate to themselves and others, and create profound changes in their lives and relationships. The desire to go off grid and have the ability to grow your own food has never been stronger than before. No matter the size of your property, Food Forest Abundance can help you design a regenerative layout that utilizes your resources in the most synergistic and sustainable manner. If you are interested in breaking free from the system, please visit www.foodforestabundance.com and use code "thefuturegen" to receive a discount on their incredible services. Show your eyes some love with a pair of daylight or sunset (or both!) blue-light blocking glasses from Ra Optics. They have graciously offered Future Generations podcast listeners 10% off any purchase. Use code FGPOD or click here to access this discount, and let us know how your glasses are treating you! One of the single best companies whose clean products have supported the optimal wellness of our family is Earthley Wellness. Long before there was a 2020, Kate Tetje and her team have stood for TRUTH, HEALTH and FREEDOM in ways that paved the way for so many of us. In collaboration with this incredible team, we are proud to offer you 10% off of your first purchase by shopping here. Are you concerned about food supply insecurity? Our family has rigorously sourced our foods for over a decade and one of our favorite sources is Farm Match and specifically for San Diego locals, "Real Food Club PMA". My kids are literally made from their maple breakfast sausage and the amazing carnitas we make from their pasture raised pork. We are thrilled to share 10% off your first order when you shop at this link. Another important way to bolster food security is by supporting local ranchers. Our favorite local regenerative ranch is Perennial Pastures. They have the best nutrient-dense meats that are 100% grass-fed and pasture-raised. You can get $10 off of your first purchase when you use the code: "FUTUREGENERATIONS" at checkout. Start shopping here.

This is a free preview of a paid episode. To hear more, visit andrewsullivan.substack.comKaren is a tech journalist and leads the Pulitzer Center's AI Spotlight Series — a program that trains journalists on how to cover AI. She was a senior editor for AI at MIT Technology Review and a reporter for the WSJ covering Chinese and US tech companies. Her first book is Empire of AI: Dreams and Nightmares in Sam Altman's OpenAI — the most accessible and readable narrative of the rise of AI.For two clips of our convo — on the environmental impact of AI, and its threats to democracy — head to our YouTube page.Other topics: raised by two computer scientists; her mechanical engineering at MIT; the birth of AI at Dartmouth; IBM Watson on Jeopardy!; how the internet made data cheap to collect; the junk info swept into AI; massive data centers; ideology driving the AI industry more than science; ChatGPT; the networking and fundraising skills of Sam Altman; his family scandal; his near ouster at OpenAI; the AI bubble and propping up 401(k)s; the threat to white-collar jobs; the brutal conditions of AI work in developing countries; Chinese authoritarianism and DeepSeek; the illiberalizing effect of Silicon Valley; Musk and Thiel; how the IDF uses AI against Hamas; autonomous weapons; how AI has done wonders with Pharma; transhumanism; chatbot safety for kids; Pope Leo's tech warnings; and AI as the ultimate apple in the Garden of Eden.Browse the Dishcast archive for an episode you might enjoy. Coming up: David Ignatius on the Trump effect globally, Mark Halperin on the domestic front, Michel Paradis on Eisenhower, Fiona Hill on Putin's war, and Arthur Brooks on the science of happiness. As always, please send any guest recs, dissents, and other comments to dish@andrewsullivan.com.